United States News Todas as matérias

Analysts say bitcoin is undervalued but likely to remain stuck in a bear market without new institutional or policy-driven catalysts.

Minnesota officials accuse the FBI of blocking state involvement in the investigation into a fatal ICE shooting.

US Vice-President JD Vance has criticised Europe and Denmark over Greenland’s strategic importance to global missile defence.

Polygon is said to be close to buying early bitcoin ATM provider Coinme in a deal valued at up to $125 million.

Polymarket is expanding its prediction markets to cover possible future US geopolitical actions after heavy trading linked to Venezuela.

Bitnomial has secured regulatory clearance to roll out prediction markets for U.S. customers focused on crypto and economic outcomes.

2025 delivered global conflict and political shockwaves - yet markets surged anyway.

Endeavour Silver Corp. (NYSE:EXK) reported full-year 2025 production of 6,486,661 ounces of silver and 37,164 ounces of gold, equivalent to 11.2 million silver equivalent ounces assuming an 80:1 ratio, representing a 48% increase from the prior year.

The Buckle (NYSE:BKE) reported robust sales performance for the five-week fiscal month ended January 3, 2026, a period encompassing the critical holiday shopping season.

Net sales increased 6.5% to $215.3 million from $202.1 million in the prior-year five-week period ended January 4, 2025.

CorMedix (NASDAQ:CRMD) reported preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, alongside initial fiscal 2026 guidance and program updates.

Menlo Park, California-based Personalis (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, reported unaudited preliminary financial and operational results for the fourth quarter and full year ended December 31, 2025.

Beverly Hills, California-based AXIL Brands (NYSE:AXIL) reported net sales of $8.1 million for its fiscal second quarter ended November 30, 2025, marking a 5.2% increase from the year-ago period.

Neogen (NASDAQ:NEOG) shares are in focus after the food and animal safety leader reported second-quarter revenue of $224.7 million, a 2.8% decline from the previous year.

TD SYNNEX (NYSE:SNX) today announced robust financial results for its fiscal fourth quarter ended November 30, 2025, demonstrating solid growth across key metrics.

Shares of software supply chain platform JFrog (NASDAQ:FROG) fell 4.7% in morning trading on January 8, 2026, as part of a broader market rotation out of the technology sector.

The decline came amid profit-taking in high-growth tech stocks following a strong recent rally, particularly in artificial-intelligence-related names.

Acrivon Therapeutics (NASDAQ:ACRV) unveiled promising interim data from its lead oncology program on Thursday, demonstrating that its biomarker-driven approach can achieve significant results in patients with hard-to-treat serous endometrial cancer.

The company’s lead candidate, ACR-368, a selective CHK1/2 inhibitor, showed a 67% confirmed objective response rate (cORR) in a subset of patients identified by Acrivon’s proprietary "OncoSignature" biomarker.

Paramount (NASDAQ:PSKY) reaffirmed its $30-per-share cash offer for Warner Bros. Discovery on Thursday, resisting pressure to sweeten the deal even after WBD’s board dismissed the proposal as a risky "leveraged buyout."

Viking Therapeutics (NASDAQ:VKTX) finished enrolling patients in a clinical trial designed to test how different dosing schedules of its experimental obesity drug can help people keep weight off, a key step in its bid to compete with established giants in the metabolic space.

Northern Technologies International Corporation (NASDAQ:NTIC) reported consolidated net sales of $23.309 million for its fiscal first quarter of 2026, a 9.2% increase from the prior-year period and marking a new quarterly record.

Eupraxia Pharmaceuticals (NASDAQ:EPRX) reported positive interim data from its ongoing Phase 1b/2a RESOLVE trial evaluating EP-104GI in patients with eosinophilic esophagitis.

RPM International (NYSE:RPM), a world leader in specialty coatings, sealants and building materials, reported record fiscal second-quarter sales of $1.91 billion for the period ended November 30, 2025, representing a 3.5% increase over the prior-year record.

Watertown, Massachusetts-based Acrivon Therapeutics (NASDAQ:ACRV) provided an interim clinical update across its precision oncology pipeline, highlighted by promising response rates for its lead candidate ACR-368 in an ongoing Phase 2b trial.

Invivyd (NASDAQ:IVVD) reported preliminary fourth-quarter net product revenue of $17.2 million for its COVID-19 antibody, PEMGARDA.

The figure marks a 25% increase over the same period last year and a 31% sequential jump from the third quarter.

Simply Good Foods (NASDAQ:SMPL) reported a 33.7% drop in net income to $25.3 million for the first quarter ended Nov. 29, 2025.

The Denver-based company was hit by a significant contraction in gross margins, which fell 590 basis points to 32.3%.